Roman Campbell
Examining the Potential Price Growth of Six Flags Entertainment Corp (FUN)
Six Flags Entertainment Corp’s recently made public that its Director Hoffman Steven E acquired Company’s shares for reported $0.25 million ...
Sky Quarry Inc’s latest rating changes from various analysts
Sky Quarry Inc’s recent filing unveils that its Former CEO Sealock David unloaded Company’s shares for reported $49364.0 on Nov ...
Keeping an Eye on Rocket Lab Corp (RKLB) After Insider Trading Activity
In a filing, Rocket Lab Corp revealed its Chief Financial Officer Spice Adam C. unloaded Company’s shares for reported $41.99 ...
Examining the Potential Price Growth of PennantPark Investment Corporation (PNNT)
PennantPark Investment Corporation’s filing revealed that its Director Briones Jose A acquired Company’s shares for reported $9985.0 on May 21 ...
Blue Bird Corp (BLBD) may enjoy gains as insiders got busy in the recent days
Blue Bird Corp’s recently made public that its Director Horlock Phil unloaded Company’s shares for reported $0.79 million on Sep ...
Taking a Closer Look At Corvus Pharmaceuticals Inc (CRVS) Following Its Recent Trade
Corvus Pharmaceuticals Inc’s recent filing unveils that its Director ORBIMED ADVISORS LLC unloaded Company’s shares for reported $4.89 million on ...
Investing in Alpha Metallurgical Resources Inc (AMR): What You Must Know
In a filing, Alpha Metallurgical Resources Inc revealed its Director Courtis Kenneth S. acquired Company’s shares for reported $8.2 million ...
Cantor Fitzgerald analysts initates an Overweight rating for Phathom Pharmaceuticals Inc (PHAT)
Phathom Pharmaceuticals Inc’s filing revealed that its Principal Accounting Officer Breedlove Robert Charles unloaded Company’s shares for reported $5573.0 on ...
H.C. Wainwright Downgrades IREN Ltd (IREN) to a Sell from a Buy
IREN Ltd’s recently made public that its Co-Chief Executive Officer Roberts Daniel John unloaded Company’s shares for reported $33.13 million ...
Understanding the Risks of Investing in Rein Therapeutics Inc (RNTX)
Rein Therapeutics Inc’s recent filing unveils that its 10% Owner Voss Capital, LP acquired Company’s shares for reported $0.25 million ...
